Grants Search Results

Modern pediatric cancer diagnosis requires the ability to perform and interpret molecular studies including gene-specific assays as well as sequencing studies to capture mutations specific to pediatric cancer that are important for diagnosis and treatment stratification. Such assays are widely available in developed countries and most hospitals have trained molecular pathologists who can carry out and interpret these studies. These are highly technical skills that require at least a year of hands-on training. In many Low and Medium Income Countries (LMIC) including Mexico, there are very few trained molecular pathologists, limiting the ability to provide adequate diagnosis for cancer patients. Dr. Ramirez-Ristori will obtain this training at the University of California, San Francisco and return to Mexico to become the very first fully trained molecular pediatric pathologist in the entire country.